Prophylactic Versus Therapeutic Caffeine for Apnea of Prematurity

• Status: Completed
• Trial end date: 2018-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Investigators hypothesized that the timing of caffeine administration in either prophylaxis or treatment of apnea of prematurity will affect the apnea response to caffeine

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mansoura University Children Hospital
• Treatments: Caffeine; Caffeine citrate; Citric Acid; Sodium Citrate

Criteria

Inclusion Criteria:

• Infants eligible for this study will be newborn infants ≤ 32 weeks with or without a diagnosis of apnea .

Exclusion Criteria:

• Newborn infants with gestational age > 32 weeks.

• Newborn infants with congenital malformations and chromosomal anomalies.

• Newborn infants with apnea of other causes .